ストックスクリーナーアプリを入手
0.793
0.00%
0.00
前日終値:
$0.793
開ける：
$0.788
24時間の取引高:
9,961
Relative Volume:
0.03
時価総額：
$40.75M
収益：
$8.72M
当期純損益:
$-6.83M
株価収益率:
-4.809
EPS:
-0.1649
ネットキャッシュフロー:
$-6.27M
1週間 パフォーマンス:
+0.38%
1か月 パフォーマンス:
-3.29%
6か月 パフォーマンス:
-11.33%
1年 パフォーマンス:
-11.80%
1日の値動き範囲:
$0.788
$0.8066
1週間の範囲:
$0.75
$0.905
52週間の値動き範囲:
$0.3954
$1.16
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
名前
Neuroone Medical Technologies Corp
セクター
電話
(952) 426-1383
住所
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.02 | 2.68B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
6.73 | 345.29M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.20 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.8499 | 389.44M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
44.78 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-05 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-29 | ダウングレード | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp (NMTC) 最新ニュース
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
JonesTrading Begins Coverage on NeuroOne Medical Technologies (NASDAQ:NMTC) - Defense World
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Neuroone medical chief business officer buys $670k in NMTC By Investing.com - Investing.com South Africa
Neuroone medical chief business officer buys $670k in NMTC - Investing.com
NeuroOne Medical Technologies Officer Acquires 1 Million Shares - TradingView
NEUROONE (NASDAQ: NMTC) CBO buys 1M shares and receives 500K options - Stock Titan
NeuroOne (NMTC) Chief Business Officer files initial Form 3 insider report - Stock Titan
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares - Yahoo Finance
Neuroone Medical stock initiated at Buy by Jones Trading - Investing.com Canada
Jones Trading Initiates Coverage on NMTC with Buy Rating and $1. - GuruFocus
NMTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NeuroOne (NMTC) schedules 2026 shareholder meeting and Rule 14a-8 cutoff - Stock Titan
Aug Final Week: What dividend growth rate does NeuroOne Medical Technologies Corporation offerJuly 2025 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn
Wall Street Zen Upgrades NeuroOne Medical Technologies (NASDAQ:NMTC) to Sell - Defense World
NeuroOne Medical Technologies Q1 Earnings Call Highlights - Defense World
NeuroOne Earnings Call Balances Growth With Cash Strain - TipRanks
NeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call - GuruFocus
Earnings call transcript: NeuroOne Medical beats Q1 2026 EPS forecast, stock dips - Investing.com Nigeria
NeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
NeuroOne (NMTC) Q1 2026 Earnings Call Transcript - The Globe and Mail
NeuroOne Reports Fiscal Q1 2026 Financial Results - TradingView
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
What to Expect from NeuroOne Medical Tech's Earnings - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2026: Everything Yo - GuruFocus
NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Update - 富途牛牛
Minne InnoNeuroOne CEO Dave Rosa talks uplisting on Nasdaq, year ahead - The Business Journals
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time - The Globe and Mail
Inside NeuroOne's brain electrode technology - MobiHealthNews
NeuroOne electrodes target motor issues and pain - MobiHealthNews
How NeuroOne's minimally invasive brain technology works - Healthcare IT News
Will NeuroOne Medical Technologies Corporation stock outperform tech sector in 2025Market Performance Recap & Verified Short-Term Trading Plans - Улправда
Will NeuroOne Medical Technologies Corporation stock deliver better than expected guidance2025 Key Lessons & Growth Focused Entry Point Reports - Улправда
Will NeuroOne Medical Technologies Corporation stock see insider buying2025 Earnings Surprises & Low Risk High Reward Ideas - Улправда
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Best Momentum Stocks to Buy for January 6th - Yahoo Finance
New Strong Buy Stocks for January 6th - Yahoo Finance
NeuroOne Medical Technologies Q4 Earnings Call Highlights - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
NeuroOne appoints Penumbra executive Jason Mills to board - Investing.com
NeuroOne(R) Appoints Jason Mills to the Board of Directors - Yahoo Finance
Is NeuroOne Medical Technologies Corporation stock in correction or buying zoneWeekly Trade Analysis & Technical Confirmation Trade Alerts - Улправда
Will NeuroOne Medical Technologies Corporation stock benefit from upcoming earnings reportsTrade Entry Report & Low Risk High Win Rate Stock Picks - ulpravda.ru
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ... By GuruFocus - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ... - Yahoo Finance
Is NeuroOne Medical Technologies Corporation stock attractive for hedge fundsJuly 2025 Momentum & High Return Stock Watch Alerts - Улправда
Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises - Investing.com
NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results - TradingView — Track All Markets
NeuroOne Medical Technologies (NASDAQ: NMTC) details FY 2025 results release - Stock Titan
NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results With Product Revenue Growth of 907% to $2.7 Million and 55.8% Gross Margin & Total Revenue Growth of 163% to $9.1 Million for Fiscal Year 2025 - Yahoo Finance
Neuroone Medical Technologies Corp (NMTC) 財務データ
収益
当期純利益
現金流量
EPS
1.61%
1.39%
大文字化:
|
ボリューム (24 時間):